HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma.

Abstract
Pheochromocytomas (PHEOs) are relatively rare catecholamine-producing tumors derived from adrenal medulla. Tumor microenvironment (TME) including neoangiogenesis has been explored in many human neoplasms but not necessarily in PHEOs. Therefore, in this study, we examined tumor infiltrating lymphocytes (CD4 and CD8), tumor associated macrophages (CD68 and CD163), sustentacular cells (S100p), and angiogenic markers (CD31 and areas of intratumoral hemorrhage) in 39 cases of PHEOs in the quantitative fashion. We then compared the results with pheochromocytoma of the adrenal gland scaled score (PASS), grading system for pheochromocytoma and paraganglioma (GAPP) and the status of intra-tumoral catecholamine-synthesizing enzymes (TH, DDC, and PNMT) as well as their clinicopathological factors. Intratumoral CD8 (p = 0.0256), CD31 (p = 0.0400), and PNMT (p = 0.0498) status was significantly higher in PHEOs with PASS <4 than PASS ≧4. In addition, intratumoral CD8+ lymphocytes were also significantly more abundant in well-than moderately differentiated PHEO according to GAPP score (p = 0.0108) and inversely correlated with tumor size (p = 0.0257). Intratumoral CD68+ cells were significantly higher in PHEOs with regular or normal histological patterns than those not (p = 0.0370) and inversely correlated with tumor size (p = 0.0457). The status of CD163 was significantly positively correlated with that of CD8 positive cells (p = 0.0032). The proportion of intratumoral hemorrhage areas was significantly higher in PHEOs with PASS ≧4 (p = 0.0172). DDC immunoreactivity in tumor cells was significantly positively correlated with PASS score (p = 0.0356) and TH status was significantly higher in PHEOs harboring normal histological patterns (p = 0.0236) and cellular monotony (p = 0.0219) than those not. Results of our present study did demonstrate that abundant CD8+ and CD68+ cells could represent a histologically low-scored tumor. In particular, PHEOs with increased intratumoral hemorrhage should be considered rather malignant. In addition, abnormal catecholamine-producing status of tumor cells such as deficient PNMT and TH and increased DDC could also represent more aggressive PHEOs.
AuthorsXin Gao, Yuto Yamazaki, Alessio Pecori, Yuta Tezuka, Yoshikiyo Ono, Kei Omata, Ryo Morimoto, Yasuhiro Nakamura, Fumitoshi Satoh, Hironobu Sasano
JournalFrontiers in endocrinology (Front Endocrinol (Lausanne)) Vol. 11 Pg. 587779 ( 2020) ISSN: 1664-2392 [Print] Switzerland
PMID33244312 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 Gao, Yamazaki, Pecori, Tezuka, Ono, Omata, Morimoto, Nakamura, Satoh and Sasano.
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Biomarkers, Tumor
  • CD68 antigen, human
  • Catecholamines
  • Tyrosine 3-Monooxygenase
  • Dopa Decarboxylase
Topics
  • Adrenal Gland Neoplasms (blood supply, epidemiology, immunology, pathology)
  • Adult
  • Aged
  • Antigens, CD (metabolism)
  • Antigens, Differentiation, Myelomonocytic (metabolism)
  • Biomarkers, Tumor (analysis)
  • CD8-Positive T-Lymphocytes (immunology)
  • Catecholamines (metabolism)
  • Dopa Decarboxylase (metabolism)
  • Female
  • Hemorrhage
  • Humans
  • Immunohistochemistry
  • Japan (epidemiology)
  • Lymphocytes, Tumor-Infiltrating (immunology)
  • Male
  • Middle Aged
  • Neovascularization, Pathologic
  • Pheochromocytoma (blood supply, epidemiology, immunology, pathology)
  • Tumor Microenvironment (immunology)
  • Tumor-Associated Macrophages (immunology)
  • Tyrosine 3-Monooxygenase (deficiency)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: